Indogulf Cropsciences Q1 FY27: Revenue up 12% QoQ at Rs 1,685 Mn, PAT falls 38% YoY

Revenue declinedEBITDA margin expansionResults View source PDF Explain this filing

IGCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.1%Reaction day

₹70.97

prior close

₹71.60

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-0.2% vs market

Pesticides & Agrochemicals peers, median of 28sector-0.5%+0.4% vs sector

On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.4 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

-0.7

15m

-0.5

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.1+0.1-0.2-0.5+0.4

Next day

+0.0+0.2-0.2-1.0+1.1

+1.0+0.6+0.4-0.9+1.9

+1.9-0.0+1.9-1.2+3.1

+2.0+0.5+1.5-1.0+3.1

+2.7+0.8+2.0-0.7+3.4

+1.5+0.6+0.9-0.4+1.8

15d

+2.2+1.3+0.9-2.3+4.4

-6.2-1.4-4.8-5.1-1.0

-19.7-0.6-19.1-9.1-10.6

—————

UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 28Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Indogulf Cropsciences posted Q1 FY27 revenue of Rs 1,685 Mn, up 12% QoQ but down 11% YoY. EBITDA was Rs 96 Mn with margin at 6%, up 47 bps YoY. PAT fell 38% YoY to Rs 24 Mn. Gross margin improved to 28% and capacity utilization rose to 70% from 52%. Company highlighted expansion in crop nutrition and biologics portfolio.

Likely market impact

Mixed quarter. Sequential revenue recovery and margin gains YoY are offset by sharp YoY decline in profits. Capacity utilization improving is a positive.